EXHIBIT 1
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Marker Therapeutics, Inc.
EXECUTED this 23rd day of December, 2024.
NEW ENTERPRISE ASSOCIATES 16, L.P.
| By: | NEA PARTNERS 16, L.P. General Partner |
| By: | NEA 16 GP, LLC General Partner |
By: *
Anthony A. Florence, Jr.
Managing Partner and Co-Chief Executive Officer
By: *
Mohamad H. Makhzoumi
Managing Partner and Co-Chief Executive Officer
NEA PARTNERS 16, L.P.
| By: | NEA 16 GP, LLC General Partner |
By: *
Anthony A. Florence, Jr.
Managing Partner and Co-Chief Executive Officer
By: *
Mohamad H. Makhzoumi
Managing Partner and Co-Chief Executive Officer
NEA 16 GP, LLC
By: *
Anthony A. Florence, Jr.
Managing Partner and Co-Chief Executive Officer
By: *
Mohamad H. Makhzoumi
Managing Partner and Co-Chief Executive Officer
*
Forest Baskett
*
Ali Behbahani
*
Carmen Chang
*
Anthony A. Florence, Jr.
*
Mohamad H. Makhzoumi
*
Scott D. Sandell
*
Paul Walker
*/s/ Zachary Bambach
Zachary Bambach
As attorney-in-fact
This Agreement relating to Schedule 13D was executed by Zachary Bambach on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached hereto as Exhibit 2.
